12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga·03/25/2026 12:05:47
Listen to the news
Gainers
iTonic Holdings (NASDAQ:ITOC) shares moved upwards by 89.5% to $0.54 during Wednesday's pre-market session. The company's market cap stands at $4.8 million.
Akari Therapeutics (NASDAQ:AKTX) shares moved upwards by 19.92% to $0.16. The company's market cap stands at $4.9 million.
Enliven Therapeutics (NASDAQ:ELVN) shares moved upwards by 18.52% to $36.92. The company's market cap stands at $1.8 billion.
bioAffinity Technologies (NASDAQ:BIAF) stock moved upwards by 14.14% to $4.52. The market value of their outstanding shares is at $17.8 million.
Virax Biolabs Group (NASDAQ:VRAX) stock increased by 13.05% to $0.2. The market value of their outstanding shares is at $1.3 million.
Artelo Biosciences (NASDAQ:ARTL) stock moved upwards by 12.78% to $6.53. The market value of their outstanding shares is at $4.1 million.
Losers
Anavex Life Sciences (NASDAQ:AVXL) stock fell 21.2% to $3.3 during Wednesday's pre-market session. The market value of their outstanding shares is at $388.2 million.
Nexalin Technology (NASDAQ:NXL) stock decreased by 14.22% to $0.35. The market value of their outstanding shares is at $7.6 million.
Aspire Biopharma Hldgs (NASDAQ:ASBP) stock fell 12.79% to $0.7. The company's market cap stands at $4.0 million.
OSR Holdings (NASDAQ:OSRH) stock decreased by 12.14% to $0.4. The company's market cap stands at $11.6 million.
Edap TMS (NASDAQ:EDAP) stock decreased by 10.24% to $3.51. The company's market cap stands at $145.0 million. As per the news, the Q4 earnings report came out today.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure. Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.